View Item 

Show simple item record

Poor Functional Status as a Risk Factor for Severe Clostridium difficile Infection in Hospitalized Older Adults

dc.contributor.authorRao, Krishnaen_US
dc.contributor.authorMicic, Dejanen_US
dc.contributor.authorChenoweth, Elizabethen_US
dc.contributor.authorDeng, Lilien_US
dc.contributor.authorGalecki, Andrzej T.en_US
dc.contributor.authorRing, Cathrinen_US
dc.contributor.authorYoung, Vincent B.en_US
dc.contributor.authorAronoff, David M.en_US
dc.contributor.authorMalani, Preeti N.en_US
dc.date.accessioned2015-08-05T16:47:54Z
dc.date.available2015-08-05T16:47:54Z
dc.date.issued2013-10en_US
dc.identifier.citationRao, Krishna; Micic, Dejan; Chenoweth, Elizabeth; Deng, Lili; Galecki, Andrzej T.; Ring, Cathrin; Young, Vincent B.; Aronoff, David M.; Malani, Preeti N. (2013). "Poor Functional Status as a Risk Factor for Severe Clostridium difficile Infection in Hospitalized Older Adults." Journal of the American Geriatrics Society 61(10): 1738-1742.en_US
dc.identifier.issn0002-8614en_US
dc.identifier.issn1532-5415en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/112304
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.othergeriatricen_US
dc.subject.otheragingen_US
dc.subject.otherClostridium difficileen_US
dc.subject.othercolitisen_US
dc.subject.otherinfectionen_US
dc.titlePoor Functional Status as a Risk Factor for Severe Clostridium difficile Infection in Hospitalized Older Adultsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/112304/1/jgs12442.pdf
dc.identifier.doi10.1111/jgs.12442en_US
dc.identifier.sourceJournal of the American Geriatrics Societyen_US
dc.identifier.citedreferenceCohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431 – 455.en_US
dc.identifier.citedreferenceBartlett JG. Antibiotic‐associated diarrhea. N Engl J Med 2002; 346: 334 – 339.en_US
dc.identifier.citedreferenceLima AA, Innes DJ Jr, Chadee K et al. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine. Lab Invest 1989; 61: 419 – 425.en_US
dc.identifier.citedreferenceHecht G, Koutsouris A, Pothoulakis C et al. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 1992; 102: 416 – 423.en_US
dc.identifier.citedreferenceBrito GA, Sullivan GW, Ciesla WP Jr et al. Clostridium difficile toxin A alters in vitro‐adherent neutrophil morphology and function. J Infect Dis 2002; 185: 1297 – 1306.en_US
dc.identifier.citedreferenceAkerlund T, Svenungsson B, Lagergren A et al. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile ‐associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 2006; 44: 353 – 358.en_US
dc.identifier.citedreferenceHenrich TJ, Krakower D, Bitton A et al. Clinical risk factors for severe Clostridium difficile ‐associated disease. Emerg Infect Dis 2009; 15: 415 – 422.en_US
dc.identifier.citedreferenceKyne L, Sougioultzis S, McFarland LV et al. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23: 653 – 659.en_US
dc.identifier.citedreferenceDas R, Feuerstadt P, Brandt LJ. Glucocorticoids are associated with increased risk of short‐term mortality in hospitalized patients with Clostridium difficile ‐associated disease. Am J Gastroenterol 2010; 105: 2040 – 2049.en_US
dc.identifier.citedreferenceWelfare MR, Lalayiannis LC, Martin KE et al. Co‐morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect 2011; 79: 359 – 363.en_US
dc.identifier.citedreferenceHigh KP, Bradley S, Loeb M et al. A new paradigm for clinical investigation of infectious syndromes in older adults: Assessment of functional status as a risk factor and outcome measure. Clin Infect Dis 2005; 40: 114 – 122.en_US
dc.identifier.citedreferenceMalani PN, Rana MM, Banerjee M et al. Staphylococcus aureus bloodstream infections: The association between age and mortality and functional status. J Am Geriatr Soc 2008; 56: 1485 – 1489.en_US
dc.identifier.citedreferenceAnderson DJ, Chen LF, Schmader KE et al. Poor functional status as a risk factor for surgical site infection due to methicillin‐resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2008; 29: 832 – 839.en_US
dc.identifier.citedreferenceMalani PN. Commentary: Debility and the risk for surgical site infection: Defining the next steps. Infect Control Hosp Epidemiol 2008; 29: 840 – 841.en_US
dc.identifier.citedreferenceKyne L, Merry C, O'Connell B et al. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999; 28: 107 – 113.en_US
dc.identifier.citedreferenceMcDonald LC, Coignard B, Dubberke E et al. Recommendations for surveillance of Clostridium difficile ‐associated disease. Infect Control Hosp Epidemiol 2007; 28: 140 – 145.en_US
dc.identifier.citedreferenceMahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J 1965; 14: 61 – 65.en_US
dc.identifier.citedreferenceBelmares J, Gerding DN, Tillotson G et al. Measuring the severity of Clostridium difficile infection: Implications for management and drug development. Expert Rev Anti Infect Ther 2008; 6: 897 – 908.en_US
dc.identifier.citedreferenceWalk ST, Micic D, Jain R et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012; 55: 1661 – 1668.en_US
dc.identifier.citedreferenceBelmares J, Gerding DN, Parada JP et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect 2007; 55: 495 – 501.en_US
dc.identifier.citedreferenceHoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006; 10: R73.en_US
dc.identifier.citedreferenceDeyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD‐9‐CM administrative databases. J Clin Epidemiol 1992; 45: 613 – 619.en_US
dc.identifier.citedreferenceCharlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373 – 383.en_US
dc.identifier.citedreferenceDelamaire M, Maugendre D, Moreno M et al. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29 – 34.en_US
dc.identifier.citedreferenceKnapp S. Diabetes and infection: Is there a link?–A mini‐review. Gerontology 2013; 59: 99 – 104.en_US
dc.identifier.citedreferenceStewart DB, Hollenbeak CS. Clostridium difficile colitis: Factors associated with outcome and assessment of mortality at a national level. J Gastrointest Surg 2011; 15: 1548 – 1555.en_US
dc.identifier.citedreferenceDalton BR, Lye‐Maccannell T, Henderson EA et al. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low‐endemicity, non‐outbreak hospital setting. Aliment Pharmacol Ther 2009; 29: 626 – 634.en_US
dc.identifier.citedreferenceDubberke ER, Reske KA, Olsen MA et al. Short‐ and long‐term attributable costs of Clostridium difficile ‐associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46: 497 – 504.en_US
dc.identifier.citedreferenceMcDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short‐stay hospitals, 1996–2003. Emerg Infect Dis 2006; 12: 409 – 415.en_US
dc.identifier.citedreferenceRedelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile ‐related mortality rates, United States, 1999–2004. Emerg Infect Dis 2007; 13: 1417 – 1419.en_US
dc.identifier.citedreferenceBurckhardt F, Friedrich A, Beier D et al. Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 2008; 14: 691 – 692.en_US
dc.identifier.citedreferenceGravel D, Miller M, Simor A et al. Health care‐associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48: 568 – 576.en_US
dc.identifier.citedreferenceCober ED, Malani PN. Clostridium difficile infection in the “oldest” old: Clinical outcomes in patients aged 80 and older. J Am Geriatr Soc 2009; 57: 659 – 662.en_US
dc.identifier.citedreferenceKuijper EJ, Coignard B, Tüll P et al. Emergence of Clostridium difficile ‐associated disease in North America and Europe. Clin Microbiol Infect 2006; 12: 2 – 18.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgs12442.pdf
Size:
77.47KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.